Moreover, FCER1A exhibits dysregulated expression in autoimmune diseases like systemic lupus erythematosus and specific cancers (e.g., breast and lung cancers), suggesting its broader role in immune regulation [37,38]. This evidence concerns the gene FCER1A and cancer.